Jay S. Stout, Chief Technology Officer at Immunovant, Inc. (IMVT), sold 3,487 shares at $39.53 ($138K) on 2026-07-08, disclosed to the SEC on 2026-07-10.
Open-market sale of $138k IMVT by Chief Technology Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $39.53 | 1,399 | $55K | 40.1% |
| 2 | $39.53 | 1,906 | $75K | 54.6% |
| 3 | $39.99 | 77 | $3K | 2.2% |
| 4 | $39.99 | 105 | $4K | 3.0% |
| Total | $39.55 avg | 3,487 | $138K | 100% |
| Filing → |
| IMVT | SELL | 2026-04-24 | $82K | — | Filing → |
| IMVT | SELL | 2026-04-10 | $252K | — | Filing → |
| IMVT | SELL | 2026-01-23 | $51K | — | Filing → |